1	Competent	competent	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	initiation	initiation	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	RNA	RNA	_	_	_	_	_	_	_
6	polymerase	polymerase	_	_	_	_	_	_	_
7	II	ii	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	cell-free	cell-free	_	_	_	_	_	_	_
10	extracts	extract	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	xeroderma	xeroderma	_	_	_	_	_	_	_
13	pigmentosum	pigmentosum	_	_	_	_	_	_	_
14	groups	group	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	D	D	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	an	an	_	_	_	_	_	_	_
20	optimized	optimize	_	_	_	_	_	_	_
21	RNA	RNA	_	_	_	_	_	_	_
22	transcription	transcription	_	_	_	_	_	_	_
23	assay	assay	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	autosomal	autosomal	_	_	_	_	_	_	_
4	recessive	recessive	_	_	_	_	_	_	_
5	disease	disease	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	xeroderma	xeroderma	_	_	_	_	_	_	_
8	pigmentosum	pigmentosum	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	XP	XP	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	can	can	_	_	_	_	_	_	_
14	result	result	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	mutations	mutation	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	any	any	_	_	_	_	_	_	_
19	one	one	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	seven	seven	_	_	_	_	_	_	_
22	genes	gene	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	designated	designate	_	_	_	_	_	_	_
25	XPA	XPA	_	_	_	_	_	_	_
26	through	through	_	_	_	_	_	_	_
27	XPG	XPG	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Of	of	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	XPB	XPB	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	XPD	XPD	_	_	_	_	_	_	_
8	genes	gene	_	_	_	_	_	_	_
9	encode	encode	_	_	_	_	_	_	_
10	proteins	protein	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	are	be	_	_	_	_	_	_	_
13	subunits	subunit	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	general	general	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	TFIIH	TFIIH	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	involved	involve	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	both	both	_	_	_	_	_	_	_
25	nucleotide	nucleotide	_	_	_	_	_	_	_
26	excision	excision	_	_	_	_	_	_	_
27	repair	repair	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	NER	NER	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	initiation	initiation	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	mRNA	mrna	_	_	_	_	_	_	_
35	transcription	transcription	_	_	_	_	_	_	_
36	by	by	_	_	_	_	_	_	_
37	RNA	RNA	_	_	_	_	_	_	_
38	polymerase	polymerase	_	_	_	_	_	_	_
39	II	ii	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	humans	human	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	mutation	mutation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	XPB	XPB	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	XPD	XPD	_	_	_	_	_	_	_
10	gene	gene	_	_	_	_	_	_	_
11	impairs	impair	_	_	_	_	_	_	_
12	NER	ner	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	resulting	result	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	hyper-sensitivity	hyper-sensitivity	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	sunlight	sunlight	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	greatly	greatly	_	_	_	_	_	_	_
21	increased	increase	_	_	_	_	_	_	_
22	skin	skin	_	_	_	_	_	_	_
23	tumor	tumor	_	_	_	_	_	_	_
24	formation	formation	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	no	no	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	deficiency	deficiency	_	_	_	_	_	_	_
6	has	have	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	demonstrated	demonstrate	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	either	either	_	_	_	_	_	_	_
11	XP-B	XP-B	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	XP-D	XP-D	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	employed	employ	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	optimized	optimize	_	_	_	_	_	_	_
6	cell-free	cell-free	_	_	_	_	_	_	_
7	RNA	RNA	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	assay	assay	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	analyze	analyze	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	XP-B	XP-B	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	XP-D	XP-D	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	growth	growth	_	_	_	_	_	_	_
4	rate	rate	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	normal	normal	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	XP-B	XP-B	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	XP-D	XP-D	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	contained	contain	_	_	_	_	_	_	_
14	reduced	reduce	_	_	_	_	_	_	_
15	amounts	amount	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	TFIIH	TFIIH	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Extracts	extract	_	_	_	_	_	_	_
2	prepared	prepare	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	XP-B	XP-B	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	XP-D	XP-D	_	_	_	_	_	_	_
7	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	exhibited	exhibit	_	_	_	_	_	_	_
10	similar	similar	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	adenovirus	adenovirus	_	_	_	_	_	_	_
16	major	major	_	_	_	_	_	_	_
17	late	late	_	_	_	_	_	_	_
18	promoter	promoter	_	_	_	_	_	_	_
19	when	when	_	_	_	_	_	_	_
20	compared	compare	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	extracts	extract	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	normal	normal	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	conclude	conclude	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	XP-B	XP-B	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	XP-D	XP-D	_	_	_	_	_	_	_
10	lymphoblastoid	lymphoblastoid	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	do	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	have	have	_	_	_	_	_	_	_
15	impaired	impair	_	_	_	_	_	_	_
16	RNA	RNA	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	consider	consider	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	possible	possible	_	_	_	_	_	_	_
5	consequences	consequence	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	reduced	reduce	_	_	_	_	_	_	_
9	cellular	cellular	_	_	_	_	_	_	_
10	content	content	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	TFIIH	TFIIH	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	clinical	clinical	_	_	_	_	_	_	_
16	symptoms	symptom	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	XP-B	XP-B	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	XP-D	XP-D	_	_	_	_	_	_	_
21	patients	patient	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	discuss	discuss	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	‘	`	_	_	_	_	_	_	_
27	conditional	conditional	_	_	_	_	_	_	_
28	phenotype	phenotype	_	_	_	_	_	_	_
29	’	'	_	_	_	_	_	_	_
30	that	that	_	_	_	_	_	_	_
31	may	may	_	_	_	_	_	_	_
32	involve	involve	_	_	_	_	_	_	_
33	an	an	_	_	_	_	_	_	_
34	impairment	impairment	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	cellular	cellular	_	_	_	_	_	_	_
37	function	function	_	_	_	_	_	_	_
38	only	only	_	_	_	_	_	_	_
39	under	under	_	_	_	_	_	_	_
40	certain	certain	_	_	_	_	_	_	_
41	growth	growth	_	_	_	_	_	_	_
42	conditions	condition	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

